| Dr Ryan Flamion, MD | |
|
303 N Meridian Street, Holland, IN 47541 | |
| (812) 536-3943 | |
| (812) 536-3222 |
| Full Name | Dr Ryan Flamion |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 20 Years |
| Location | 303 N Meridian Street, Holland, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649319054 | NPI | - | NPPES |
| 200905150 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | R1142 (Kentucky) | Secondary |
| 207Q00000X | Family Medicine | 01065030A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Heart To Heart Hospice Of Southwest Indiana Llc | Jasper, IN | Hospice |
| Kindred Hospice | Evansville, IN | Hospice |
| Memorial Hospital And Health Care Center | Jasper, IN | Hospital |
| St Charles Health Campus | Jasper, IN | Nursing home |
| Scenic Hills At The Monastery | Ferdinand, IN | Nursing home |
| Willowdale Village | Dale, IN | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Little Company Of Mary Hospital Of Indiana Inc | 4587578042 | 167 |
News Archive
An antiretroviral drug already in widespread use in the developing world to prevent the transmission of HIV from infected mothers to their newborns during childbirth has also been found to substantially cut the risk of subsequent HIV transmission during breast-feeding.
To create an optimal workflow that encompasses the diverse computing requirements of bioinformatics research, the Malaysia Genomics Institute (MGI) selected SGI to design a unique SGI hybrid computing solution.
Regenerative medicine, or the use of specially grown tissues and cells to treat injuries and diseases, has been successful in treating disorders of a number of organs, including heart, pancreas, and cartilage. However, efforts to treat disorders of the corneal endothelium, a single cell layer on the inner surface of the cornea, with regenerative techniques have been less effective. Now, a group of scientists has developed a method that enhances the adhesion of injected corneal endothelial cells (CECs), allowing for successful corneal transplantation to repair pathological dysfunctions.
SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion products, announced today that REPEL-CV, the company's bioresorbable adhesion barrier film for the reduction of adhesions following cardiac surgery, has received approval from the Brazilian Ministry of Health for use in all patients who undergo open-heart surgery.
Women are underrepresented in the field of academic surgery, but women surgeons are earning a disproportionate share of research grants from the National Institutes of Health, a new study has found.
› Verified 6 days ago
| Entity Name | Little Company Of Mary Hospital Of Indiana Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114120128 PECOS PAC ID: 4587578042 Enrollment ID: O20031118000733 |
News Archive
An antiretroviral drug already in widespread use in the developing world to prevent the transmission of HIV from infected mothers to their newborns during childbirth has also been found to substantially cut the risk of subsequent HIV transmission during breast-feeding.
To create an optimal workflow that encompasses the diverse computing requirements of bioinformatics research, the Malaysia Genomics Institute (MGI) selected SGI to design a unique SGI hybrid computing solution.
Regenerative medicine, or the use of specially grown tissues and cells to treat injuries and diseases, has been successful in treating disorders of a number of organs, including heart, pancreas, and cartilage. However, efforts to treat disorders of the corneal endothelium, a single cell layer on the inner surface of the cornea, with regenerative techniques have been less effective. Now, a group of scientists has developed a method that enhances the adhesion of injected corneal endothelial cells (CECs), allowing for successful corneal transplantation to repair pathological dysfunctions.
SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion products, announced today that REPEL-CV, the company's bioresorbable adhesion barrier film for the reduction of adhesions following cardiac surgery, has received approval from the Brazilian Ministry of Health for use in all patients who undergo open-heart surgery.
Women are underrepresented in the field of academic surgery, but women surgeons are earning a disproportionate share of research grants from the National Institutes of Health, a new study has found.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ryan Flamion, MD Po Box 1028, Jasper, IN 47547-1028 Ph: (812) 481-8493 | Dr Ryan Flamion, MD 303 N Meridian Street, Holland, IN 47541 Ph: (812) 536-3943 |
News Archive
An antiretroviral drug already in widespread use in the developing world to prevent the transmission of HIV from infected mothers to their newborns during childbirth has also been found to substantially cut the risk of subsequent HIV transmission during breast-feeding.
To create an optimal workflow that encompasses the diverse computing requirements of bioinformatics research, the Malaysia Genomics Institute (MGI) selected SGI to design a unique SGI hybrid computing solution.
Regenerative medicine, or the use of specially grown tissues and cells to treat injuries and diseases, has been successful in treating disorders of a number of organs, including heart, pancreas, and cartilage. However, efforts to treat disorders of the corneal endothelium, a single cell layer on the inner surface of the cornea, with regenerative techniques have been less effective. Now, a group of scientists has developed a method that enhances the adhesion of injected corneal endothelial cells (CECs), allowing for successful corneal transplantation to repair pathological dysfunctions.
SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion products, announced today that REPEL-CV, the company's bioresorbable adhesion barrier film for the reduction of adhesions following cardiac surgery, has received approval from the Brazilian Ministry of Health for use in all patients who undergo open-heart surgery.
Women are underrepresented in the field of academic surgery, but women surgeons are earning a disproportionate share of research grants from the National Institutes of Health, a new study has found.
› Verified 6 days ago